Gagnon Securities’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.84M Buy
29,743
+670
+2% +$96.3K 0.89% 36
2025
Q4
$4.15M Buy
29,073
+322
+1% +$43.1K 0.84% 33
2025
Q3
$3.45M Sell
28,751
-3,564
-11% -$452K 0.69% 39
2025
Q2
$4.27M Buy
32,315
+276
+0.9% +$37.4K 0.87% 34
2025
Q1
$4.45M Buy
32,039
+3,158
+11% +$490K 0.98% 30
2024
Q4
$4.48M Buy
28,881
+137
+0.5% +$23.2K 0.9% 30
2024
Q3
$5.24M Buy
28,744
+5,113
+22% +$757K 1.04% 30
2024
Q2
$2.81M Buy
23,631
+511
+2% +$53.8K 0.63% 36
2024
Q1
$2.48M Buy
23,120
+767
+3% +$76.3K 0.59% 37
2023
Q4
$2.23M Buy
22,353
+8,411
+60% +$822K 0.54% 37
2023
Q3
$1.66M Buy
13,942
+708
+5% +$106K 0.42% 43
2023
Q2
$2.36M Buy
13,234
+1,160
+10% +$213K 0.49% 41
2023
Q1
$1.99M Buy
+12,074
New +$2.08M 0.42% 43

Other funds holding ICUI

Gagnon Securities's ICUI Position: Q1 2026 in Review

Gagnon Securities increased its ICU Medical (ICUI) stake by 2.3% in Q1 2026, buying an estimated $96.3K and bringing the position to 29,743 shares worth $3.84M. The position accounts for 0.89% of the portfolio, ranked #36.

Gagnon Securities first reported a position in ICUI in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.24M in Q3 2024. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Gagnon Securities held 29,743 shares of ICU Medical worth $3.84M as of Q1 2026.
  • Gagnon Securities bought 670 ICU Medical shares in Q1 2026, an estimated $96.3K.
  • ICU Medical made up 0.89% of Gagnon Securities's portfolio in Q1 2026, its #36 holding.
  • Gagnon Securities first reported a position in ICU Medical in Q1 2023 and has held it in 13 quarters since.
  • Gagnon Securities's ICU Medical position peaked at $5.24M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Gagnon Securities's 13F filing for Q1 2026, filed 22 Apr 2026.